ritanserin has been researched along with Acute Disease in 4 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the selective serotonin-2 antagonist ritanserin was investigated in an open study of patients with schizophrenia." | 9.07 | An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. ( Eriksson, B; Farde, L; Nordström, AL; Wiesel, FA, 1994) |
| "We investigated the effects of ketanserin, a S 2 (5-hydroxytryptamine 2; 5-HT 2)-serotonergic receptor antagonist, on cerulein-induced pancreatitis in the rat." | 7.68 | Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. ( Furuta, S; Homma, T; Kawa, S; Kobayashi, M; Koiwai, T; Oguchi, H; Terashima, M, 1992) |
| "The efficacy of ritanserin to obtain a better improvement in patients with mania seems to support the 5-HT hypothesis of bipolar disorder." | 5.10 | Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial. ( Akhondzadeh, S; Amini, H; Mohajari, H; Reza Mohammadi, M, 2003) |
| "The effect of the selective serotonin-2 antagonist ritanserin was investigated in an open study of patients with schizophrenia." | 5.07 | An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. ( Eriksson, B; Farde, L; Nordström, AL; Wiesel, FA, 1994) |
| "We investigated the effects of ketanserin, a S 2 (5-hydroxytryptamine 2; 5-HT 2)-serotonergic receptor antagonist, on cerulein-induced pancreatitis in the rat." | 3.68 | Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. ( Furuta, S; Homma, T; Kawa, S; Kobayashi, M; Koiwai, T; Oguchi, H; Terashima, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhondzadeh, S | 1 |
| Mohajari, H | 1 |
| Reza Mohammadi, M | 1 |
| Amini, H | 1 |
| Wiesel, FA | 1 |
| Nordström, AL | 1 |
| Farde, L | 1 |
| Eriksson, B | 1 |
| Mechan, AO | 1 |
| Esteban, B | 1 |
| O'Shea, E | 1 |
| Elliott, JM | 1 |
| Colado, MI | 1 |
| Green, AR | 1 |
| Oguchi, H | 1 |
| Terashima, M | 1 |
| Koiwai, T | 1 |
| Kawa, S | 1 |
| Furuta, S | 1 |
| Kobayashi, M | 1 |
| Homma, T | 1 |
2 trials available for ritanserin and Acute Disease
| Article | Year |
|---|---|
Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
Topics: Acute Disease; Adult; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; | 2003 |
An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Biogenic Monoamines; Hemodynamics; Humans; Male; Prolact | 1994 |
2 other studies available for ritanserin and Acute Disease
| Article | Year |
|---|---|
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striat | 2002 |
Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Dose-Response Relationship, Drug; Ketanserin; Male; Pa | 1992 |